Exosome Diagnostics To Present Data At The 26th AACR-National Cancer Institute-EORTC International Conference On Molecular Targets And Cancer Therapeutics

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Exosome Diagnostics, Inc., a developer of revolutionary, biofluid-based molecular diagnostics, announced that the company will present two posters at the 26th AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, taking place November 5-9 at the Hynes Convention Center in Boston, Mass.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC